Previous close | 1,448.00 |
Open | 1,449.00 |
Bid | 1,433.00 x N/A |
Ask | 1,435.00 x N/A |
Day's range | 1,412.00 - 1,452.00 |
52-week range | 1,128.00 - 1,926.00 |
Volume | |
Avg. volume | 92,754 |
Market cap | 1.932B |
Beta (5Y monthly) | 0.06 |
PE ratio (TTM) | 47,800.00 |
EPS (TTM) | 0.03 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 16 Jun 2016 |
1y target est | N/A |
Key Insights Institutions' substantial holdings in Indivior implies that they have significant influence over the...
Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation of the expected primary listing of the Company's shares on Nasdaq , members of Indivior's senior leadership team will be hosting an analyst teach-in event today in New York City. The event, which will be webcast (see details below), is intended to provide an in-depth overview of Indivior's growth and value creation path. During the event, the Company will reconfirm its unchanged FY 2024
Despite facing cyberattack disruptions, Indivior reports robust revenue growth and reaffirms full-year guidance.